Home / 2019 / May

Apoteket AB utökar distributionen av VagiVital®

  • -

Peptonic Medical AB (‘Peptonic’ eller ‘Bolaget’) meddelar idag att Apoteket AB utökar distributionen av Peptonics egenvårdsprodukt VagiVital® till att från och med maj månad omfatta 250 apoteksbutiker från dagens 30 butiker.

Read More

Market Notice 115/19 – Trading halt in PEPTONIC Medical AB

  • -

With reference to today’s press release from Spotlight Stock Market a trading halt will take place. Information about the share: Shortname: PMEDISIN-code: SE0005962206Orderbook-ID: 412CCFI: ESVUFRFISN: PEPTONICME/SHOrganization number: 556776-3064LEI: 213800QRUS3DHXGTFA20 Stockholm May

Read More

Recent Comments

    All press releases on Spotlightstockmarket.com

    All published press releases from PEPTONIC medical is available on spotlightstockmarket.com.

    About us

    PEPTONIC Medical is an innovative Swedish pharmaceutical company developing and commercializing safe and effective products for the treatment of menopausal symptoms, such as vaginal atrophy. VagiVital® is a registered trademark of PEPTONIC Medical. The product is being commercialised for the non-prescription use for the treatment of vaginal atrophy.

    The Company was founded in 2009 and its first candidate drug product is Vagitocin® – an estrogen-free oxytocin based product for the treatment of vaginal atrophy in clinical development phase 2.

    Oxytocin has a long history of safe and effective medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women.